医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Jacobs Named Lead Architect for Major Redevelopment of Sydney’s Concord Hospital

2017年10月03日 PM08:45
このエントリーをはてなブックマークに追加


 

DALLAS

Jacobs Engineering Group Inc. (NYSE:JEC) has been appointed by New South Wales Health Infrastructure as lead architect for the $270 million (AU$341 million) redevelopment of Sydney’s Concord Hospital.

The redevelopment will involve the delivery of a new comprehensive cancer center, additional inpatient capacity, enhanced ambulatory care services and Australia’s first comprehensive care center for retired service men, women and their families – the Rusty Priest Centre for Rehabilitation and Aged Care.

“This win reinforces our global reputation as a leader in healthcare facility design,” said Jacobs Buildings and Infrastructure Asia Pacific Senior Vice President Patrick Hill. “Concord has a long history of caring for veterans and their families, and we look forward to leveraging our health infrastructure knowledge in developing a facility that acknowledges their contribution and provides the patient care they need.”

This facility will provide specialist services including substance and alcohol abuse programs, and services for mild traumatic brain injury, specialist pain management, psychological well-being, rehabilitation and family support.

Jacobs was previously selected by New South Wales Health Infrastructure to carry out all the architectural work for Sydney’s Blacktown Hospital, which received three awards at the 2017 Design & Health International Academy Awards, including the prize for Best International Health Project Under 40,000 Square Meters.

Jacobs is one of the world’s largest and most diverse providers of full-spectrum technical, professional and construction services for industrial, commercial and government organizations globally. The company employs over 54,000 people and operates in more than 25 countries around the world. For more information, visit www.jacobs.com.

Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our Form 10-K for the year ended September 30, 2016, and in particular the discussions contained under Items 1 – Business, 1A – Risk Factors, 3 – Legal Proceedings, and 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171003005409/en/

CONTACT

Jacobs Engineering Group Inc.
Salim Rahimi, 214.583.8428

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Konica Minolta and Innovation Network Corporation of Japan Close Acquisition of Ambry Genetics
  • Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan
  • Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
  • 武田薬品がALK陽性非小細胞肺がんでのALUNBRIGTM(ブリガチニブ)のピボタル第2相ALTA試験の最新データを発表
  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″